Mission
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer treatment to Montana, Idaho, and Wyoming through National Cancer Institute (NCI) sponsored clinical research.
Public Charity
Montana Cancer Consortium
Montana Cancer Consortium, of Billings, MT, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $997K in revenue, $873K in expenses, $848K in total assets. 3 publicly reported grants to this organization, totaling roughly $107K, appear in IRS filings.
EIN: 810503295
Billings, MT
Latest filing: 2025
Total Revenue$997K
Total Expenses$873K
Total Assets$848K
Grant Records3
Funding Total$107K
Filing Years2021–2025
Sample Grants Received
CANCER RESEARCH
$50,500
CANCER RESEARCH
$45,502
INSTITUTIONAL SUPPORT FOR CANCER RESEARCH
$11,160
Showing up to 5 of 3 total records — full history available with membership.
Officers & Directors
Secretary/Treasurer
Amanda Dinsdale
Director
Christopher Goulet Md
Director
James Hueftle Md
Vice-President
Jeffrey Allen Md
President
John Schallenkamp Md
Director
Justin Thomas Md
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $997K | $873K | $848K |
| 2024 | $1.3M | $915K | $723K |
| 2023 | $607K | $858K | $361K |
| 2022 | $897K | $859K | $607K |
| 2021 | $1.1M | $1.1M | $570K |
Between 2021 and 2025, reported annual revenue declined from $1.1M to $997K (-13%), with total assets most recently reported at $848K.
Interactive year-over-year charts and full filing details available with membership.